Adhera Therapeutics Buy Hold or Sell Recommendation

ATRXDelisted Stock  USD 0.72  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Adhera Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Adhera Therapeutics given historical horizon and risk tolerance towards Adhera Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Adhera Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
In addition, we conduct extensive research on individual companies such as Adhera and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Adhera Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Adhera Therapeutics Buy or Sell Advice

The Adhera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adhera Therapeutics. Macroaxis does not own or have any residual interests in Adhera Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adhera Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Adhera TherapeuticsBuy Adhera Therapeutics
Not Rated
For the selected time horizon Adhera Therapeutics has a Risk Adjusted Performance of 0.0374, Jensen Alpha of 0.944, Total Risk Alpha of (1.68), Sortino Ratio of 0.0176 and Treynor Ratio of (0.14)
We provide trade advice to complement the prevailing expert consensus on Adhera Therapeutics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Adhera Therapeutics is not overpriced, please confirm all Adhera Therapeutics fundamentals, including its ebitda and the relationship between the current ratio and current liabilities . As Adhera Therapeutics appears to be a penny stock we also recommend to validate its gross profit numbers.

Adhera Therapeutics Trading Alerts and Improvement Suggestions

Adhera Therapeutics is not yet fully synchronised with the market data
Adhera Therapeutics has some characteristics of a very speculative penny stock
Adhera Therapeutics has a very high chance of going through financial distress in the upcoming years
Adhera Therapeutics currently holds 7.35 M in liabilities with Debt to Equity (D/E) ratio of 56.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Adhera Therapeutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Adhera Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Adhera Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adhera Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adhera to invest in growth at high rates of return. When we think about Adhera Therapeutics' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (6.35 M) with loss before overhead, payroll, taxes, and interest of (157 K).
Adhera Therapeutics currently holds about 849 K in cash with (665 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 22.0% of Adhera Therapeutics shares are held by company insiders

Adhera Therapeutics Returns Distribution Density

The distribution of Adhera Therapeutics' historical returns is an attempt to chart the uncertainty of Adhera Therapeutics' future price movements. The chart of the probability distribution of Adhera Therapeutics daily returns describes the distribution of returns around its average expected value. We use Adhera Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adhera Therapeutics returns is essential to provide solid investment advice for Adhera Therapeutics.
Mean Return
0.53
Value At Risk
-32
Potential Upside
32.56
Standard Deviation
14.64
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adhera Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Adhera Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adhera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Adhera Therapeutics Buy or Sell Advice

When is the right time to buy or sell Adhera Therapeutics? Buying financial instruments such as Adhera Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Adhera Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SPAC Thematic Idea Now

SPAC
SPAC Theme
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Adhera Pink Sheet

If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators